CZC-24758

N/A

Report date: 2025/03/18 18:22:55
NME

Base Information

Drug NameCZC-24758
Drug Alias NameCZC-24758
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPI3-kinase class I inhibitors
TargetsPI3-kinase class I
Therapy Area/IndicationsAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesCellzome Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesCellzome Ltd
Active IndicationsN/A
Inactive IndicationsAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A